Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • DelMar Pharma amends follow-on

    DelMar Pharmaceuticals Inc. (OTCQX:DMPI), Vancouver, B.C. Business: Cancer Date announced: 2015-05-14 Type: Follow-on To be raised: Up to $5.8 million Shares: 7 million Price prior: $0.71 Underwriters: Maxim Group; Roth…

    Published on 5/18/2015
  • Antares completes follow-on

    Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Business: Drug delivery Date completed: 2015-05-06 Type: Follow-on Raised: $46 million Shares: 23 million Price: $2 Shares after offering: 154.8 million Underwriters: Piper…

    Published on 5/18/2015
  • BeiGene completes venture financing

    BeiGene Co. Ltd., Beijing, China Business: Cancer, Autoimmune Date completed: 2015-05-12 Type: Venture financing Raised: RMB600 million ($96.6 million) Investors: Hillhouse Capital; CITIC PE; Fidelity; T. Rowe Price; …

    Published on 5/18/2015
  • BiondVax completes follow-on

    BiondVax Pharmaceuticals Ltd. (Tel Aviv:BNDX; NASDAQ:BVXV), Ness Ziona, Israel Business: Infectious Date completed: 2015-05-11 Type: Follow-on Raised: $9.6 million Shares: 1.9 million Price: $5 Shares after offering: 3.…

    Published on 5/18/2015
  • Cartiva completes venture financing

    Cartiva Inc., Alpharetta, Ga. Business: Autoimmune Date completed: 2015-05-11 Type: Venture financing Raised: $8.5 million Investors: New Enterprise Associates; Windham Venture Partners

    Published on 5/18/2015
  • Denali Therapeutics completes venture financing

    Denali Therapeutics Inc., San Francisco, Calif. Business: Neurology Date completed: 2015-05-14 Type: Venture financing Raised: $217 million Investors: Fidelity; Arch Venture Partners; Flagship Ventures; Crestline …

    Published on 5/18/2015
  • Diagnostic BioSystems completes venture financing

    Diagnostic BioSystems Inc., Pleasanton, Calif. Business: Diagnostic, Supply/Service, Antibodies Date completed: 2015-05-11 Type: Venture financing Raised: Not disclosed Investor: BroadOak Capital Partners Note: The …

    Published on 5/18/2015
  • Formula Pharmaceuticals completes venture financing

    Formula Pharmaceuticals Inc., Berwyn, Pa. Business: Cancer, Infectious Date completed: 2015-05-11 Type: Venture financing Raised: Not disclosed Note: Formula Pharmaceuticals raised an undisclosed amount in a convertible…

    Published on 5/18/2015
  • Galapagos completes follow-on

    Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Date completed: 2015-05-13 Type: Follow-on Raised: $210.1 million Shares: 5 million Price: $42.05…

    Published on 5/18/2015
  • Galapagos completes private placement

    Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Date completed: 2015-05-13 Type: Private placement Raised: EUR56.7 million ($63.3 million) Shares…

    Published on 5/18/2015
  • Imprimis completes debt financing

    Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY), San Diego, Calif. Business: Neurology, Drug delivery Date completed: 2015-05-12 Type: Debt financing Raised: $10 million Investor: Life Sciences Alternative Funding Note: …

    Published on 5/18/2015
  • Jaguar Animal Health completes IPO

    Jaguar Animal Health Inc. (NASDAQ:JAGX), San Francisco, Calif. Business: Veterinary Date completed: 2015-05-13 Type: IPO Raised: $20 million Shares: 2.9 million Price: $7 Shares after offering: 8.1 million Underwriters:…

    Published on 5/18/2015
  • JHL Biotech completes venture financing

    JHL Biotech Inc., Zhubei, Taiwan Business: Antibodies, Supply/Service Date completed: 2015-05-11 Type: Venture financing Raised: $45.6 million Investors: Milestone Capital; Sungent BioVenture; Liwick Investment …

    Published on 5/18/2015
  • Juventas completes venture financing

    Juventas Therapeutics Inc., Cleveland, Ohio Business: Cardiovascular, Dermatology, Gene/Cell therapy Date completed: 2015-05-12 Type: Venture financing Raised: $6 million Investor: Oxford Finance Note: Juventas is …

    Published on 5/18/2015
  • Juventas completes venture financing

    Juventas Therapeutics Inc., Cleveland, Ohio Business: Cardiovascular, Dermatology, Gene/Cell therapy Date completed: 2015-05-12 Type: Venture financing Raised: $7.5 million Investors: Green Cross; Posco BioVentures; new…

    Published on 5/18/2015
  • Medifocus completes private placement

    Medifocus Inc. (TSX-V:MFS; OTCQX:MDFZF), Vancouver, B.C. Business: Cancer Date completed: 2015-05-12 Type: Private placement Raised: C$2.1 million ($1.8 million) Shares: 38.8 million Price: C$0.06 Shares after offering:…

    Published on 5/18/2015
  • NantWorks completes venture financing

    NantWorks LLC, Los Angeles, Calif. Business: Other Date completed: 2015-05-12 Type: Venture financing Raised: $100 million Investor: Not disclosed Note: A single, undisclosed investor invested $100 million in NantWorks …

    Published on 5/18/2015
  • Navidea completes debt financing

    Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Date completed: 2015-05-11 Type: Debt financing Raised: $50 million Investor: CRG Note: Navidea drew down $50 million of a new $60 million…

    Published on 5/18/2015
  • NuSirt Biopharma completes venture financing

    NuSirt Biopharma Inc., Nashville, Tenn. Business: Endocrine/Metabolic, Hepatic, Inflammation Date completed: 2015-05-13 Type: Venture financing Raised: $6 million Investors: Hatteras Venture Partners; Mountain Group …

    Published on 5/18/2015
  • OncoCyte completes venture financing

    OncoCyte Corp., Alameda, Calif. Business: Cancer, Gene/Cell therapy Date completed: 2015-05-14 Type: Venture financing Raised: $3.3 million Investor: Existing investors Note: The company also converted $3.3 million of …

    Published on 5/18/2015
  • Precision BioSciences completes venture financing

    Precision BioSciences Inc., Durham, N.C. Business: Genomics Date completed: 2015-05-11 Type: Venture financing Raised: $25.6 million Investors: VenBio LLC; Fidelity Biosciences; Amgen Ventures; Baxter Ventures; Osage …

    Published on 5/18/2015
  • Prima BioMed completes private placement

    Prima BioMed Ltd. (ASX:PRR; NASDAQ:PBMD), Sydney, Australia Business: Cancer, Infectious Date completed: 2015-05-14 Type: Private placement Raised: A$1.2 million ($985,722) Shares: 72.2 million Price: A$0.02 Shares …

    Published on 5/18/2015
  • Sensorion completes IPO

    Sensorion S.A. (Euronext:ALSEN), Clapiers, France Business: Other Date completed: 2015-04-16 Type: IPO Raised: EUR8.2 million ($8.8 million) Shares: 1.8 million Price: EUR4.54 Shares after offering: 5.1 million …

    Published on 5/18/2015
  • Affimed financial update

    Affimed N.V. (NASDAQ:AFMD), Heidelberg, Germany Business: Cancer, Inflammation, Antibodies Date announced: 2015-05-12 Note: Affimed raised $5.4 million through the sale of 750,000 shares at $7.15 to cover the …

    Published on 5/18/2015
  • aTyr financial update

    aTyr Pharma Inc. (NASDAQ:LIFE), San Diego, Calif. Business: Hematology, Inflammation, Cancer Date announced: 2015-05-12 Note: aTyr raised $11.3 million through the sale of 804,000 shares at $14 to cover the …

    Published on 5/18/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993